ZA200402733B - New oripavine derivatives and their uses as medicines - Google Patents

New oripavine derivatives and their uses as medicines Download PDF

Info

Publication number
ZA200402733B
ZA200402733B ZA2004/02733A ZA200402733A ZA200402733B ZA 200402733 B ZA200402733 B ZA 200402733B ZA 2004/02733 A ZA2004/02733 A ZA 2004/02733A ZA 200402733 A ZA200402733 A ZA 200402733A ZA 200402733 B ZA200402733 B ZA 200402733B
Authority
ZA
South Africa
Prior art keywords
compound
pharmaceutically acceptable
acceptable salt
toxic pharmaceutically
methyl
Prior art date
Application number
ZA2004/02733A
Other languages
English (en)
Inventor
Wang Yaping
Zhong Bohua
Qin Boyi
Gong Zehui
Liu Yongshao
Original Assignee
Inst Of Pharmacology And Toxicology Acad Of Military Medical Sciences
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Of Pharmacology And Toxicology Acad Of Military Medical Sciences filed Critical Inst Of Pharmacology And Toxicology Acad Of Military Medical Sciences
Publication of ZA200402733B publication Critical patent/ZA200402733B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/09—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: containing 4aH-8, 9 c-Iminoethano- phenanthro [4, 5-b, c, d] furan ring systems condensed with carbocyclic rings or ring systems
    • C07D489/10—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: containing 4aH-8, 9 c-Iminoethano- phenanthro [4, 5-b, c, d] furan ring systems condensed with carbocyclic rings or ring systems with a bridge between positions 6 and 14
    • C07D489/12—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: containing 4aH-8, 9 c-Iminoethano- phenanthro [4, 5-b, c, d] furan ring systems condensed with carbocyclic rings or ring systems with a bridge between positions 6 and 14 the bridge containing only two carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Addiction (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ZA2004/02733A 2001-09-14 2004-04-07 New oripavine derivatives and their uses as medicines ZA200402733B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CNB011421495A CN1233645C (zh) 2001-09-14 2001-09-14 新的东罂粟碱衍生物及其医药用途
PCT/CN2002/000642 WO2003024972A1 (en) 2001-09-14 2002-09-13 New oripavine derivatives and their uses as medicines

Publications (1)

Publication Number Publication Date
ZA200402733B true ZA200402733B (en) 2005-02-23

Family

ID=4676657

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2004/02733A ZA200402733B (en) 2001-09-14 2004-04-07 New oripavine derivatives and their uses as medicines

Country Status (8)

Country Link
EP (1) EP1439179B1 (enExample)
JP (1) JP4532109B2 (enExample)
CN (1) CN1233645C (enExample)
AT (1) ATE390428T1 (enExample)
DE (1) DE60225827D1 (enExample)
MX (1) MXPA04002422A (enExample)
WO (1) WO2003024972A1 (enExample)
ZA (1) ZA200402733B (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1939920B (zh) * 2005-09-29 2011-08-31 中国人民解放军军事医学科学院毒物药物研究所 东罂粟碱类化合物及其医药用途
ES2329296T3 (es) * 2006-01-05 2009-11-24 Mallinckrodt, Inc. El uso de oripavina como material de partida para buprenorfina.
CA2674915C (en) 2006-10-17 2015-06-30 Penick Corporation Process for preparing oxymorphone
US20080125592A1 (en) 2006-10-17 2008-05-29 Penick Corporation Process for preparing oxymorphone, naltrexone, and buprenorphine
US8546572B2 (en) * 2008-03-31 2013-10-01 Sun Pharmaceutical Industries Limited Process for the preparation of morphinane analogues
AU2009300390B2 (en) * 2008-09-30 2015-05-14 SpecGx LLC Processes for the production of buprenorphine with reduced impurity formation
ES2462756T3 (es) 2008-09-30 2014-05-26 Mallinckrodt Llc Procedimientos de síntesis de alcaloides opiáceos con formación reducida de impurezas
NZ592005A (en) 2008-09-30 2013-03-28 Mallinckrodt Llc Process for the preparation of a N-alkylated ketomorphinan by selective catalytiC hydrogen transfer reduction
ES2477190T3 (es) 2008-09-30 2014-07-16 Mallinckrodt Llc Procedimiento de reciclaje para aumentar el rendimiento de una reacción de Grignard en la preparación de derivados alcaloides opiáceos
CA2738089C (en) 2008-09-30 2017-07-18 Mallinckrodt Inc. Processes for the hydrogenation of opiate alkaloid derivatives
EP2342207B1 (en) 2008-09-30 2015-11-11 Mallinckrodt LLC Processes for the alkylation of norbuprenorphine with reduced impurity formation
TWI630208B (zh) * 2008-12-08 2018-07-21 歐陸斯迪公司 二氫羥戊甲嗎啡
CN102462680B (zh) * 2010-11-04 2016-08-03 中国人民解放军军事医学科学院毒物药物研究所 噻吩诺啡的长效缓释微球及其组合物和制备方法
CN102382118A (zh) * 2011-05-23 2012-03-21 浙江仙琚制药股份有限公司 一种7ɑ-乙酰基-6,14-乙基桥四氢蒂巴因的制备方法
GB201309654D0 (en) 2013-05-30 2013-07-17 Euro Celtique Sa Method
EP3023427A1 (en) 2014-11-19 2016-05-25 Siegfried AG Improved method of manufacturing buprenorphine and analogues thereof from oripavine
EP3067357A1 (en) 2015-03-11 2016-09-14 Siegfried AG Method of manufacturing stereoisomers of buprenorphine and analogues thereof
GB2550566A (en) 2016-05-19 2017-11-29 Chapelglade Ltd Mattress evaluation system and method
CN108530452B (zh) * 2017-03-01 2023-02-03 泰州华元医药科技有限公司 高效抗成瘾药物
EP4613751A1 (en) 2024-03-07 2025-09-10 Siegfried AG Method of making chemical compounds useful for the synthesis of buprenorphine

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB925723A (en) * 1960-09-05 1963-05-08 J F Macfarlan & Company Ltd Novel thebaine derivatives
US3474101A (en) * 1960-09-05 1969-10-21 Reckitt & Sons Ltd Thebaine and oripavine derivatives
DE2230154A1 (de) * 1972-06-21 1974-01-17 Boehringer Sohn Ingelheim N-(heteroaryl-methyl)-6,14-endoaetheno7alpha-hydroxyalkyl-tetrahydro-nororipavine und -thebaine, deren hydrierungsprodukte und saeureadditionssalze sowie verfahren zu deren herstellung
KR100204659B1 (ko) * 1996-05-28 1999-06-15 강재헌 신규한 부프레노핀계 진통제용 화합물

Also Published As

Publication number Publication date
JP2005506985A (ja) 2005-03-10
WO2003024972A1 (en) 2003-03-27
CN1233645C (zh) 2005-12-28
EP1439179A4 (en) 2005-10-12
ATE390428T1 (de) 2008-04-15
EP1439179B1 (en) 2008-03-26
WO2003024972A8 (en) 2004-06-17
JP4532109B2 (ja) 2010-08-25
MXPA04002422A (es) 2005-04-11
CN1408714A (zh) 2003-04-09
EP1439179A1 (en) 2004-07-21
DE60225827D1 (de) 2008-05-08

Similar Documents

Publication Publication Date Title
ZA200402733B (en) New oripavine derivatives and their uses as medicines
US4722928A (en) N-oxide prodrug derivatives of 3-hydroxy morphinans and partial morphinans having improved oral bioavailability, pharmaceutical compositions, and processes
EP1359146B1 (en) 4-aryl piperidines as opioid receptor binding agents
JP5017629B2 (ja) ６−アミノ−モルフィナン誘導体、その製造法と適用
AU2002227135A1 (en) 8- substituted-2, 6-methano-3-benzazocines and 3-substituted morphinanes as opioid receptor binding agents
JP2012254984A (ja) 代謝安定性鎮痛薬、疼痛薬物療法及び他の物質の合成
WO1987001703A1 (en) Potent, selective opioid receptor agonists and antagonists
DE10229842A1 (de) Morphinanderivate und deren quartäre Ammoniumsalze substituiert in Position 14, Herstellungsverfahren und Verwendung
CA2319627A1 (en) Therapeutic compounds
US4990617A (en) N-oxide prodrug derivatives of 3-hydroxy morphinans and partial morphinans and derivatives
US7119100B2 (en) Oripavine derivatives and their uses as pharmaceuticals
US6284769B1 (en) Nonpeptide kappa opioid receptor antagonists
JPS5919096B2 (ja) ベンゾモルフィナン誘導体の製造法
US4232028A (en) 17-Cyclobutylmethyl-4,5α-epoxy-3-hydroxy-14-methoxy-8α-methylmorphinan-6-one, and method of treating pain with it
AU757975B2 (en) Therapeutic compounds